In addition, another BCL2 inhibitor, HA14-1, can also overcome the radiation therapy resistance of PCa cells through increasing ROS generation and c-Jun N-terminal kinase (JNK) activation [42]. This evidence concerns the gene MAPK8 and posterior cortical atrophy.